Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19

Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19

Abstract Introduction This real-world study assessed the effectiveness of bebtelovimab (BEB) versus nirmatrelvir/ritonavir (NR) among outpatients with COVID-19 during the Omicron variant era. Methods We conducted a cohort study evaluating patients treated with BEB or NR from February to August 2022...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher G. Rowan, Russell M. Nichols, Neil Dhopeshwarkar, Jennifer M. Alyea, Baojin Zhu, Sengwee Toh, K. Arnold Chan, Elsie L. Grace
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-12-01
Series:Pulmonary Therapy
Subjects:
Bebtelovimab
COVID-19
Nirmatrelvir
Omicron variant
Observational study
Paxlovid
Online Access:https://doi.org/10.1007/s41030-024-00284-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s41030-024-00284-w

Similar Items